ASX:IME - ImExHS Stock Price, News & Analysis

Today's Range N/A
50-Day Range
A$0.05
MA: A$0.06
A$0.07
52-Week Range N/A
Volume1.31 million shs
Average VolumeN/A
Market Capitalization$44.43 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ImExHS Limited develops software solutions for running and managing radiology facilities in Colombia, Mexico, Peru, Ecuador, Costa Rica, and internationally. It offers Hiruko radiology information system (RIP) that manages the workflow in diagnostic imaging services; Hiruko picture archiving and communication system (PACS), a technologic platform that stores diagnostic images; Hiruko DictaPACS, a solutions for radiology centers; Hiruko TLRad tool used to interconnect with several radiology centers and view the images remotely, as well from mobile devices; and Hiruko MedBurner that automates the burning of CDs or DVDs. The company also provides nuance, a voice recognition system that include Speech Magic 7, SpeechAnyWhere 360, and DRAGON solutions. ImExHS Limited is headquartered in Bogotá, Colombia.

Industry, Sector and Symbol

Industry Software - Application
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone57 1 316 4890

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.78 million
Book ValueA$0.01 per share

Profitability

Miscellaneous

Employees54
Market Cap$44.43 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IME News and Ratings via Email

Sign-up to receive the latest news and ratings for IME and its competitors with MarketBeat's FREE daily newsletter.


ImExHS (ASX:IME) Frequently Asked Questions

What is ImExHS's stock symbol?

ImExHS trades on the ASX under the ticker symbol "IME."

Has ImExHS been receiving favorable news coverage?

News articles about IME stock have been trending positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. ImExHS earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the near term. View News Stories for ImExHS.

Who are some of ImExHS's key competitors?

Who are ImExHS's key executives?

ImExHS's management team includes the folowing people:
  • Dr. German Arango, MD, CEO & Director
  • Mr. Tony Thomas, Chief Financial Officer
  • Mr. Andres Vanegas, Chief Sales Officer
  • Dr. Jorge Marin, Chief Medical Officer
  • Mr. Peter G. Webse B.Bus, FGIA, FCIS, FCPA, MAICD, Company Sec. (Age 56)

How big of a company is ImExHS?

ImExHS has a market capitalization of $0.00 and generates $5.78 million in revenue each year. ImExHS employs 54 workers across the globe.View Additional Information About ImExHS.

What is ImExHS's official website?

The official website for ImExHS is http://imexhs.com/.

How can I contact ImExHS?

The company can be reached via phone at 57 1 316 4890.


MarketBeat Community Rating for ImExHS (ASX IME)

Community Ranking:  3.9 out of 5 (star star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  27
MarketBeat's community ratings are surveys of what our community members think about ImExHS and other stocks. Vote "Outperform" if you believe IME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IME will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Featured Article: What is the Rule of 72?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel